An International,Multicenter Evaluation of Comprehensive Medication Management by Pharmacists in ICU Recovery Centers

Abstract

Background

Post-intensive care syndrome (PICS) is defined as a new or worsening impairment in physical, cognitive, or mental health following critical illness. Intensive care unit recovery centers (ICU-RC) are one means to treat patients who have PICS. The purpose of this study is to describe the role of pharmacists in ICU-RCs.

Research Question

What is the number and type of medication interventions made by a pharmacist at an ICU-RC at 12 different centers?

Study Design and Methods

This prospective, observational study was conducted in 12 intensive care units (ICUs)/ICU-RCs between September 2019 and July 2021. A full medication review was conducted by a pharmacist on patients seen at the ICU-RC.

Results

507 patients were referred to the ICU-RC. Of these patients, 474 attended the ICU-RC and 472 had a full medication review performed by a pharmacist. Baseline demographic and hospital course data were obtained from the electronic health record and at the ICU-RC appointment. Pharmacy interventions were made in 397 (84%) patients. The median number of pharmacy interventions per patient was 2 (interquartile range [IQR] = 1,3). Medications were stopped and started in 124 (26%) and 91 (19%) patients, respectively. The number of patients that had a dose decreased and a dose increased was 51 (11%) and 43 (9%), respectively. There was no difference in the median total number of medications that the patient was prescribed at the start and end of the patient visit (10, IQR = 5, 15). Adverse drug event (ADE) preventive measures were implemented in 115 (24%) patients. ADE events were identified in 69 (15%) patients. Medication interactions were identified in 30 (6%) patients.

Interpretation

A pharmacist plays an integral role in an ICU-RC resulting in the identification, prevention, and treatment of medication-related problems. This paper should serve as a call to action on the importance of the inclusion of a pharmacist in ICU-RC clinics.

Keywords

post-intensive care syndrome post-intensive care syndrome clinic pharmacist medication reconciliation adverse drug event

Get full access to this article

View all access options for this article.

References

Pandharipande

Girard

Jackson

, et al. Long-term cognitive impairment after critical illness. N Engl J Med. 2013;369(14):1306-1316.

Jackson

Pandharipande

Girard

, et al. Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study. Lancet Respir Med. 2014;2(5):369-379.

Marra

Pandharipande

Girard

, et al. Co-occurrence of post-intensive care syndrome problems among 406 survivors of critical illness*. Crit Care Med. 2018;46(9):1393-1401.

Maley

Brewster

Mayoral

, et al. Resilience in survivors of critical illness in the context of the survivors’ experience and recovery. Ann Am Thorac Soc. 2016;13(8):1351-1360.

Needham

Davidson

Cohen

, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders’ conference. Crit Care Med. 2012;40(2):502-509. doi:10.1097/CCM.0b013e318232da75.

Health NIo. COVID-19 treatment guidelines panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. 2022. Accessed March 13, 2022. https://wwwcovid19treatmentguidelinesnihgov/

Al-Aly

Xie

Bowe

. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259-264.

Parker

Brigham

Connolly

, et al. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care. Lancet Respir Med. 2021;9(11):1328-1341.

Huggins

Bloom

Stollings

Camp

Sevin

Jackson

. A clinic model: post-intensive care syndrome and post-intensive care syndrome-family. AACN Adv Crit Care. 2016;27(2):204-211.

10.

Griffiths

Barber

Cuthbertson

Young

. A national survey of intensive care follow-up clinics. Anaesthesia. 2006;61(10):950-955.

11.

Sevin

Bloom

Jackson

Wang

Ely

Stollings

. Comprehensive care of ICU survivors: development and implementation of an ICU recovery center. J Crit Care. 2018;46:141-148.

12.

Cuthbertson

Rattray

Campbell

, et al. The PRaCTICaL study of nurse led, intensive care follow-up programmes for improving long term outcomes from critical illness: a pragmatic randomised controlled trial. Br Med J. 2009;339(oct16 1):b3723.

13.

Jensen

Egerod

Bestle

, et al. A recovery program to improve quality of life, sense of coherence and psychological health in ICU survivors: a multicenter randomized controlled trial, the RAPIT study. Intensive Care Med. 2016;42(11):1733-1743.

14.

Stollings

Bloom

Wang

Ely

Jackson

Sevin

. Critical care pharmacists and medication management in an ICU recovery center. Ann Pharmacother. 2018;52(8):713-723.

15.

Bottom-Tanzer

Poyant

Louzada

, et al. High occurrence of postintensive care syndrome identified in surgical ICU survivors after implementation of a multidisciplinary clinic. J Trauma Acute Care Surg. 2021;91(2):406-412.

16.

Mohammad

Eze

Marshall

, et al. The impact of a clinical pharmacist in an interprofessional intensive care unit recovery clinic providing care to intensive care unit survivors. J Am Coll Clin Pharm. 2022;5(10):1027-1038.

17.

MacTavish

Quasim

Shaw

, et al. Impact of a pharmacist intervention at an intensive care rehabilitation clinic. BMJ Open Qual. 2019;8(3):e000580.

18.

MacTavish

Quasim

Purdie

, et al. Medication-related problems in intensive care unit survivors: Learning from a multicenter program. Ann Am Thorac Soc. 2020;17(10):1326-1329.

19.

Mohammad

Betthauser

Korona

, et al. Clinical pharmacist services within intensive care unit recovery clinics: an opinion of the critical care practice and research network of the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2020;3(7):1369-1379.

20.

Cai

Campbell

Khan

Callahan

Boustani

. Long-term anticholinergic use and the aging brain. Alzheimers Dement. 2013;9(4):377-385.

21.

Campbell

Perkins

Bradt

, et al. Association of anticholinergic burden with cognitive impairment and health care utilization among a diverse ambulatory older adult population. Pharmacotherapy. 2016;36(11):1123-1131.

22.

Harris

Taylor

Thielke

Payne

Gonzalez

Conde

. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support [research support, N.I.H., extramural]. J Biomed Inform. 2009;42(2):377-381.

23.

Pene

Pickkers

Hotchkiss

. Is this critically ill patient immunocompromised? Intensive Care Med. 2016;42(6):1051-1054.

24.

Kroger

Duchin

Vazquez

. General best practice guidelines for immunization: best practices of the Advisory Committee on Immunization Practices (ACIP).

25.

Tully

Hammond

Jarrell

Kruer

. Evaluation of medication errors at the transition of care from an ICU to non-ICU location. Crit Care Med. 2019;47(4):543-549.

26.

Morandi

Vasilevskis

Pandharipande

, et al. Inappropriate medication prescriptions in elderly adults surviving an intensive care unit hospitalization. J Am Geriatr Soc. 2013;61(7):1128-1134.

27.

Tomichek

Stollings

Pandharipande

Chandrasekhar

Ely

Girard

. Antipsychotic prescribing patterns during and after critical illness: a prospective cohort study. Crit Care. 2016;20(1):378.

28.

Kram

Brooks

. Implications of atypical antipsychotic prescribing in the intensive care unit. J Crit Care. 2015;30(4):814-818.

29.

Flurie

Gonzales

Tata

Millstein

Gulati

. Hospital delirium treatment: continuation of antipsychotic therapy from the intensive care unit to discharge. Am J Health Syst Pharm. 2015;72(23 Suppl 3):S133-S139.

30.

Jasiak

Middleton

Camamo

Erstad

Snyder

Huckleberry

. Evaluation of discontinuation of atypical antipsychotics prescribed for ICU delirium. J Pharm Pract. 2013;26(3):253-256.

31.

Rowe

Hamilton

Curtis

, et al. Risk factors for discharge on a new antipsychotic medication after admission to an intensive care unit. J Crit Care. 2015;30(6):1283-1286.

32.

Murphy

Stevens

Ferrentino

, et al. Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit. Pharmacotherapy. 2008;28(8):968-976.

33.

Pavlov

Muravyev

Amoateng-Adjepong

Manthous

. Inappropriate discharge on bronchodilators and acid-blocking medications after ICU admission: importance of medication reconciliation. Respir Care. 2014;59(10):1524-1529.

34.

Shin

. Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review. Ther Clin Risk Manag. 2015;11:649-657.

35.

McDonald

Jones

Green

Jayaraman

Lee

. Reduction of inappropriate exit prescriptions for proton pump inhibitors: a before-after study using education paired with a web-based quality-improvement tool. J Hosp Med. 2015;10(5):281-286.

36.

Kripalani

Roumie

Dalal

, et al. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012;157(1):1-10.

37.

Hugtenburg

Borgsteede

Beckeringh

. Medication review and patient counselling at discharge from the hospital by community pharmacists. Pharm World Sci. 2009;31(6):630-637.

38.

Walker

Bernstein

Jones

, et al. Impact of a pharmacist-facilitated hospital discharge program: a quasi-experimental study. Arch Intern Med. 2009;169(21):2003-2010.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.07 MB